MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Frazier Healthcare Ventures
Finance & Acquisitions: Frazier
Parents
Frazier Healthcare Ventures
Children
*Portfolio Companies: Frazier
2009: $50 million round of venture capital financing, led by Skyline Ventures and Frazier Healthcare Ventures. Bay City Capital and InterWest Partners (2009)
2012: Other investors in the C round include Venrock, Advanced Technology Ventures, Frazier Healthcare Ventures and Panorama Capital. (2012)
2014: Powervision's Series D funding included Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures.
2014: Venture firms that still have a stake in Cadence include Domain Associates, Frazier Healthcare Ventures, Wellington Management, Versant Ventures, Bay City Capital, and NEA
Calistoga Pharmaceuticals is a private, venture backed company with top tier investors including Alta Partners, Amgen Ventures, Frazier Healthcare, Latterell Venture Partners, Quogue Capital and Three Arch Partners. (2011)
Company is backed by Canaan Partners, Intersouth Partners, Skyline Ventures, Frazier Healthcare Ventures, and Three Arch Partners.
Domain Associates LLC, Frazier Healthcare Ventures, InterWest Partners, Meritech Capital, Montreux Equity Partners, OrbiMed Advisors LLC, Versant Venture Management LLC
Investors: Frazier Healthcare Ventures, 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital and Emergent Medical Partners
Investors: Frazier Healthcare Ventures, Alta Partners, 5 AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and the Wellcome Trust
Investors: Quogue Capital, Alta Partners, Amgen Ventures, Frazier Healthcare, Three Arch Partners and Latterell Venture Partners
LABSCO sold to private equity firm Frazier Healthcare (2011)
Led by Bessemer Venture Partners, Frazier Healthcare, and Third Rock Ventures
New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.
New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences, OrbiMed Advisors and Adams Street Partners
Returning shareholders Frazier Healthcare Ventures and Boston Millennia Partners also joined.
The series F round was led by New Leaf Venture Partners, joined by new investors Pappas Ventures and Morningside Group. Existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures also pa
Zeltiq’s largest shareholders are venture investors Advanced Technology Ventures (30.7 percent), Frazier Healthcare Ventures (28.8 percent), Venrock (20.3 percent), and Aisling Capital (13.2 percent).
Jumps
*Key People: Frazier
Organization & Developments: Frazier